BIOSPECIFICS TECHNOLOGIES CO's ticker is BSTC and the CUSIP is 090931106. A total of 68 filers reported holding BIOSPECIFICS TECHNOLOGIES CO in Q3 2014. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $152,000 | -6.2% | 3,266 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $162,000 | -9.5% | 3,266 | 0.0% | 0.00% | 0.0% |
| Q1 2017 | $179,000 | -9.6% | 3,266 | -8.3% | 0.00% | 0.0% |
| Q4 2016 | $198,000 | +21.5% | 3,563 | 0.0% | 0.00% | 0.0% |
| Q3 2016 | $163,000 | +14.8% | 3,563 | 0.0% | 0.00% | 0.0% |
| Q2 2016 | $142,000 | +21.4% | 3,563 | +6.5% | 0.00% | 0.0% |
| Q1 2016 | $117,000 | -14.0% | 3,346 | +5.4% | 0.00% | 0.0% |
| Q4 2015 | $136,000 | -1.4% | 3,175 | 0.0% | 0.00% | 0.0% |
| Q3 2015 | $138,000 | -15.9% | 3,175 | 0.0% | 0.00% | 0.0% |
| Q2 2015 | $164,000 | +56.2% | 3,175 | +18.4% | 0.00% | – |
| Q1 2015 | $105,000 | 0.0% | 2,682 | -1.7% | 0.00% | – |
| Q4 2014 | $105,000 | +9.4% | 2,727 | 0.0% | 0.00% | – |
| Q3 2014 | $96,000 | +35.2% | 2,727 | +2.9% | 0.00% | – |
| Q2 2014 | $71,000 | +108.8% | 2,651 | +19.9% | 0.00% | – |
| Q2 2013 | $34,000 | – | 2,211 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| APIS CAPITAL ADVISORS, LLC | 36,000 | $2,244,000 | 2.71% |
| JW Asset Management, LLC | 73,649 | $4,591,000 | 2.36% |
| THB ASSET MANAGEMENT | 87,491 | $5,453,000 | 0.79% |
| RICE HALL JAMES & ASSOCIATES, LLC | 315,972 | $19,695,000 | 0.63% |
| EAM Global Investors LLC | 22,789 | $1,420,000 | 0.63% |
| Elk Creek Partners, LLC | 73,936 | $4,608,000 | 0.33% |
| Matarin Capital Management, LLC | 69,964 | $4,361,000 | 0.32% |
| EAM Investors, LLC | 17,696 | $1,103,000 | 0.27% |
| CADENCE CAPITAL MANAGEMENT LLC | 37,196 | $2,318,000 | 0.21% |
| Cavalier Investments, LLC | 7,800 | $486,000 | 0.20% |